We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

135 hedge funds and large institutions have $1.11B invested in Immunogen Inc in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 46 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $8.63M | Put options by funds: $8.36M

8% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 50

4% less funds holding

Funds holding: 141135 (-6)

12% less capital invested

Capital invested by funds: $1.25B → $1.11B (-$148M)

29% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 17

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
135
Holders Change
-6
Holders Change %
-4.26%
% of All Funds
3.92%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
12
Increased
46
Reduced
50
Closed
17
Calls
$8.63M
Puts
$8.36M
Net Calls
+$269K
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$186M +$1.13M +73,700 +0.6%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$179M -$8.9M -579,400 -5%
ClearBridge Investments
3
ClearBridge Investments
New York
$129M +$25M +1,626,020 +23%
Vanguard Group
4
Vanguard Group
Pennsylvania
$74M +$3.23M +210,012 +4%
SAM
5
Sectoral Asset Management
Quebec, Canada
$51.5M -$2.15M -139,611 -4%
BB
6
BB Biotech
Switzerland
$47.3M -$768K -50,000 -2%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$46.7M -$2.72M -176,820 -5%
BFA
8
BlackRock Fund Advisors
California
$45.4M -$764K -49,722 -2%
First Trust Advisors
9
First Trust Advisors
Illinois
$38.1M +$7.15M +465,028 +22%
State Street
10
State Street
Massachusetts
$36.9M -$1.81M -117,555 -4%
Norges Bank
11
Norges Bank
Norway
$34.8M -$475K -30,915 -1%
BIT
12
BlackRock Institutional Trust
California
$34.4M +$178K +11,611 +0.5%
AG
13
Artal Group
Luxembourg
$24.2M
Northern Trust
14
Northern Trust
Illinois
$18M +$364K +23,656 +2%
GIM
15
Granahan Investment Management
Massachusetts
$16.7M +$556K +36,171 +3%
PA
16
Pinnacle Associates
New York
$13.5M -$303K -19,696 -2%
Wells Fargo
17
Wells Fargo
California
$9.59M +$3.54M +230,636 +55%
Invesco
18
Invesco
Georgia
$8.07M +$8.42M +547,616 +20,973%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$6.4M +$20.8K +1,353 +0.3%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$6.21M +$229K +14,933 +4%
Morgan Stanley
21
Morgan Stanley
New York
$5.77M -$1.07M -69,487 -15%
Deutsche Bank
22
Deutsche Bank
Germany
$5.5M -$2.44M -158,477 -30%
TCIM
23
TIAA CREF Investment Management
New York
$5.15M -$113K -7,337 -2%
MAA
24
Managed Account Advisors
New Jersey
$3.72M +$1.16M +75,647 +43%
BIM
25
BlackRock Investment Management
Delaware
$3.6M -$88K -5,724 -2%

IMGN Hedge Fund Activity: Q4 2013 in Review

135 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2013, worth a combined $1.11B — down 12% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of IMGN and 12 opened new positions — a net loss of 5 holders — while 50 trimmed existing stakes and 46 added.

The largest buyer was ClearBridge Investments, adding an estimated $25M. The largest seller was Fidelity Investments, cutting an estimated $8.9M.

  • 135 institutional investors held Immunogen Inc (IMGN) as of Q4 2013, down from 141 in Q3 2013.
  • Funds reported $1.11B of Immunogen Inc stock for Q4 2013, down 12% quarter-over-quarter.
  • 12 funds opened new Immunogen Inc positions in Q4 2013 and 17 closed out, a net change of -5 holders.
  • The largest Immunogen Inc buyer in Q4 2013 was ClearBridge Investments, an estimated $25M added.
  • The largest Immunogen Inc seller in Q4 2013 was Fidelity Investments, an estimated $8.9M sold.

Based on aggregated 13F filings for Q4 2013.